These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25487734)

  • 41. Co-delivery of plasmid-encoded cytokines modulates the immune response to a DNA vaccine delivered by in vivo electroporation.
    Yen HH; Scheerlinck JP
    Vaccine; 2007 Mar; 25(14):2575-82. PubMed ID: 17224210
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potentiation of an anthrax DNA vaccine with electroporation.
    Luxembourg A; Hannaman D; Nolan E; Ellefsen B; Nakamura G; Chau L; Tellez O; Little S; Bernard R
    Vaccine; 2008 Sep; 26(40):5216-22. PubMed ID: 18462850
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HIV-DNA Given with or without Intradermal Electroporation Is Safe and Highly Immunogenic in Healthy Swedish HIV-1 DNA/MVA Vaccinees: A Phase I Randomized Trial.
    Nilsson C; Hejdeman B; Godoy-Ramirez K; Tecleab T; Scarlatti G; Bråve A; Earl PL; Stout RR; Robb ML; Shattock RJ; Biberfeld G; Sandström E; Wahren B
    PLoS One; 2015; 10(6):e0131748. PubMed ID: 26121679
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device.
    Broderick KE; Shen X; Soderholm J; Lin F; McCoy J; Khan AS; Yan J; Morrow MP; Patel A; Kobinger GP; Kemmerrer S; Weiner DB; Sardesai NY
    Gene Ther; 2011 Mar; 18(3):258-65. PubMed ID: 20962869
    [TBL] [Abstract][Full Text] [Related]  

  • 45. What you always needed to know about electroporation based DNA vaccines.
    Gothelf A; Gehl J
    Hum Vaccin Immunother; 2012 Nov; 8(11):1694-702. PubMed ID: 23111168
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Parameters for DNA vaccination using adaptive constant-current electroporation in mouse and pig models.
    Draghia-Akli R; Khan AS; Brown PA; Pope MA; Wu L; Hirao L; Weiner DB
    Vaccine; 2008 Sep; 26(40):5230-7. PubMed ID: 18450333
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation.
    Roos AK; Moreno S; Leder C; Pavlenko M; King A; Pisa P
    Mol Ther; 2006 Feb; 13(2):320-7. PubMed ID: 16185933
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Different domains of glycoprotein 96 influence HPV16 E7 DNA vaccine potency via electroporation mediated delivery in tumor mice model.
    Daemi A; Bolhassani A; Rafati S; Zahedifard F; Hosseinzadeh S; Doustdari F
    Immunol Lett; 2012 Dec; 148(2):117-25. PubMed ID: 23085605
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optimization of skin electroporation in mice to increase tolerability of DNA vaccine delivery to patients.
    Roos AK; Eriksson F; Walters DC; Pisa P; King AD
    Mol Ther; 2009 Sep; 17(9):1637-42. PubMed ID: 19532140
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Self-replicating alphavirus RNA vaccines.
    Ljungberg K; Liljeström P
    Expert Rev Vaccines; 2015 Feb; 14(2):177-94. PubMed ID: 25269775
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A single HBsAg DNA vaccination in combination with electroporation elicits long-term antibody responses in sheep.
    Babiuk S; Tsang C; van Drunen Littel-van den Hurk S; Babiuk LA; Griebel PJ
    Bioelectrochemistry; 2007 May; 70(2):269-74. PubMed ID: 17118714
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Persistent antibody and T cell responses induced by HIV-1 DNA vaccine delivered by electroporation.
    Cristillo AD; Weiss D; Hudacik L; Restrepo S; Galmin L; Suschak J; Draghia-Akli R; Markham P; Pal R
    Biochem Biophys Res Commun; 2008 Feb; 366(1):29-35. PubMed ID: 18036339
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vivo electroporation improves therapeutic potency of a DNA vaccine targeting hepadnaviral proteins.
    Khawaja G; Buronfosse T; Jamard C; Abdul F; Guerret S; Zoulim F; Luxembourg A; Hannaman D; Evans CF; Hartmann D; Cova L
    Virology; 2012 Nov; 433(1):192-202. PubMed ID: 22921316
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Electroporation-mediated gene delivery.
    Young JL; Dean DA
    Adv Genet; 2015; 89():49-88. PubMed ID: 25620008
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heparanase DNA vaccine delivered by electroporation induces humoral immunity and cytoimmunity in animal models.
    Fu J; Zhao B; Dong Z; Sun Y; Luan H; Shen X; Gao X; Gong F; Li S; Song H
    Vaccine; 2012 Mar; 30(12):2187-96. PubMed ID: 22240343
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Taking electroporation-based delivery of DNA vaccination into humans: a generic clinical protocol.
    Tjelle TE; Rabussay D; Ottensmeier C; Mathiesen I; Kjeken R
    Methods Mol Biol; 2008; 423():497-507. PubMed ID: 18370225
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic immunization with plasmid DNA mediated by electrotransfer.
    Rochard A; Scherman D; Bigey P
    Hum Gene Ther; 2011 Jul; 22(7):789-98. PubMed ID: 21631165
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DNA electroporation prime and protein boost strategy enhances humoral immunity of tuberculosis DNA vaccines in mice and non-human primates.
    Li Z; Zhang H; Fan X; Zhang Y; Huang J; Liu Q; Tjelle TE; Mathiesen I; Kjeken R; Xiong S
    Vaccine; 2006 May; 24(21):4565-8. PubMed ID: 16154246
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhancement of DNA vaccine potency by electroporation in vivo.
    Selby M; Goldbeck C; Pertile T; Walsh R; Ulmer J
    J Biotechnol; 2000 Sep; 83(1-2):147-52. PubMed ID: 11000470
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An electrically active microneedle array for electroporation.
    Choi SO; Kim YC; Park JH; Hutcheson J; Gill HS; Yoon YK; Prausnitz MR; Allen MG
    Biomed Microdevices; 2010 Apr; 12(2):263-73. PubMed ID: 20012696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.